All In Biotech

Drug Trial Radar · NCT07615660

Clinical Study of CVL006 Combination With 9MW2821

Phase Ib/II Clinical Study of CVL006 Combination With 9MW2821 in Advanced Solid Tumors

Last checked: Nov 19, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

108

Planned (sponsor's estimate)

Start

May 15, 2026

Primary completion

Apr 30, 2029

Study completion Apr 30, 2029

Sponsor

Lead sponsor
Convalife (Shanghai) Co., Ltd.Industry
Sponsor type
Industry
First posted
May 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multi-center, open-label, dose-escalation and dose-optimized phase I/II clinical trial. Objective: To determine the safety, tolerability, PK characteristics and preliminary efficacy data of CVL006 combined with 9MW821 patients with advanced solid tumors.

Conditions

  • Advanced Solid Tumor

Interventions

  • CVL006 in combination with 9MW2821Drug

    CVL006 in combination with 9MW2821

  • CVL006 in combination with 9MW2821Drug

    CVL006 in combination with 9MW2821

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Outcome MeasureTime frame: From date of randomization until the date of first documented progression, assessed up to 36 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.